Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply.
作者信息
Vadillo Cristina, Nieto Maria Asuncion, Romero-Bueno Fredeswinda, Leon Leticia, Sanchez-Pernaute Olga, Rodriguez-Nieto Maria Jesus, Freites Dalifer, Jover Leon Juan Angel, Álvarez-Sala Jose Luis, Abasolo Lydia
机构信息
Rheumatology Department, Hospital Clínico San Carlos, Madrid, Spain.
Pneumology Department, Hospital Clínico San Carlos, Madrid, Spain.
出版信息
Rheumatology (Oxford). 2020 Aug 1;59(8):2181-2182. doi: 10.1093/rheumatology/keaa160.
PMID:32447385
Abstract
摘要
相似文献
1
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry: reply.关于《利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：来自NEREA注册研究的数据》的评论：回复
Rheumatology (Oxford). 2020 Aug 1;59(8):2181-2182. doi: 10.1093/rheumatology/keaa160.
2
Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.评论：利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：来自NEREA注册研究的数据。
Rheumatology (Oxford). 2020 Aug 1;59(8):2180. doi: 10.1093/rheumatology/keaa171.
3
Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry.利妥昔单抗在减缓类风湿关节炎相关间质性肺病进展中的疗效：NEREA 登记处的数据。
Rheumatology (Oxford). 2020 Aug 1;59(8):2099-2108. doi: 10.1093/rheumatology/kez673.
4
Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.利妥昔单抗治疗类风湿关节炎相关间质性肺病
Intern Med J. 2020 Mar;50(3):330-336. doi: 10.1111/imj.14306.
5
Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.利妥昔单抗对类风湿关节炎相关间质性肺疾病进展的影响：单中心10年经验
Rheumatology (Oxford). 2017 Aug 1;56(8):1348-1357. doi: 10.1093/rheumatology/kex072.
6
Rheumatoid arthritis associated interstitial lung disease: a review.类风湿关节炎相关间质性肺疾病：综述
Medicina (B Aires). 2014;74(2):158-65.
7
Comment on: Impact of interstitial lung disease on clinical remission of rheumatoid arthritis: results from the IORRA cohort.评论：间质性肺病对类风湿关节炎临床缓解的影响：来自IORRA队列研究的结果
Rheumatology (Oxford). 2024 Apr 2;63(4):e132-e133. doi: 10.1093/rheumatology/kead512.
8
Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients.阿巴西普对类风湿关节炎患者间质性肺疾病进展的可能影响。
Respir Investig. 2016 Sep;54(5):376-9. doi: 10.1016/j.resinv.2016.03.001. Epub 2016 Apr 20.
9
Comment on: Impact of interstitial lung disease on clinical remission of rheumatoid arthritis: results from the IORRA cohort: Reply.关于《间质性肺疾病对类风湿关节炎临床缓解的影响：来自IORRA队列的结果》的评论：回复
Rheumatology (Oxford). 2024 Apr 2;63(4):e134-e135. doi: 10.1093/rheumatology/kead511.
10
Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?难治性类风湿关节炎及相关间质性肺疾病：阿巴西普会是答案吗？
J Clin Rheumatol. 2017 Mar;23(2):125-126. doi: 10.1097/RHU.0000000000000481.
Zotero 插件